1. An Overview of the Applications of Nanomaterials and Nanodevices in the Food Industry / M. Shafiq [et al.] // Foods. 2020. Vol. 9, №2. P. 148.
2. E. Pérez-Herrero. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy / E. Pérez-Herrero, A. Fernández-Medarde // Eur. J. Pharm. Biopharm. 2015. Vol. 93. P. 52–79.
3. D. M. Moss. Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling / D. M. Moss, M. Siccardi // Br. J. Pharmacol. 2014. Vol. 171. №17. P. 3963–3979.
4. E. Samaridou. Lipid nanoparticles for nucleic acid delivery: Current perspectives / E. Samaridou, J. Heyes, P. Lutwyche // Adv. Drug. Deliv. Rev. 2020. Vol. 154–155. P. 37–63.
5. Chemistry of Lipid Nanoparticles for RNA Delivery / Y. Eygeris [et al.] // Acc. Chem. Res. 2022. Vol. 55. №1. P. 2–12.
6. D. A. Tomalia. In quest of a systematic framework for unifying and defining nanoscience / D. A. Tomalia // J. Nanopart. Res. 2009. Vol. 11. №6. P. 1251–1310.
7. How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo / D. Shcharbin [et al.] // J. Control. Release. 2014. Vol. 181, №1. P. 40–52.
8. Therapeutic nanoparticles for drug delivery in cancer / K. Cho [et al.] // Clin. Cancer Res. 2008. Vol. 14. №5. P. 1310–1316.
9. M. Wang. Targeting nanoparticles to cancer / M. Wang, M. Thanou // Pharmacol. Res. 2010. Vol. 62. №2. P. 90–99.
10. M. Rippe. Design of soft nanocarriers combining hyaluronic acid with another functional polymer for cancer therapy and other biomedical applications / M. Rippe, V. Cosenza, R. Auzély-Velty // Pharmaceutics. 2019. Vol. 11, №7. P. 338.
11. Carbon Nanotubes in Cancer Therapy and Drug Delivery / A. Elhissi [et al.] // Emerging Nanotechnologies in Dentistry. 2012. Vol. 2012. P. 347–363.
12. Nanomedicine therapeutic approaches to overcome cancer drug resistance / J. L. Markman [et al.] // Adv. Drug Deliv. Rev. 2013. Vol. 65. №13–14. P. 1866–1879.
13. Nanomaterials in combating cancer: Therapeutic applications and developments / S. Nazir [et al.] // Nanomedicine. 2014. Vol. 10. №1. P. 19–34.
14. R. K. Jain. Delivering nanomedicine to solid tumors / R. K. Jain, T. Stylianopoulos // Nat. Rev. Clin. Oncol. 2010. Vol. 7. №11. P. 653–664.
15. F. Danhier. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery / F. Danhier, O. Feron, V. Préat // J. Control. Release. 2010. Vol. 148. №2. P. 135–146.
16. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress / T. Lammers [et al.] // J. Control. Release. 2012. Vol. 161. №2. P. 175–187.
17. E. Blanco. Principles of nanoparticle design for overcoming biological barriers to drug delivery / E. Blanco, H. Shen, M. Ferrari // Nat. Biotechnol. 2015. Vol. 33. №9. P. 941–951.
18. Y.H. Bae. Targeted drug delivery to tumors: Myths, reality and possibility / Y. H. Bae, K. Park // J. Control. Release. 2011. Vol. 153. №3. P. 198–205.
